Bellevue Group Ag Exact Sciences Corp Transaction History

Bellevue Group Ag

  • $4.31 Billion
  • Q1 2025

A detailed history of Bellevue Group Ag transactions in Exact Sciences Corp stock. As of the latest transaction made, Bellevue Group Ag holds 579,074 shares of EXAS stock, worth $30.8 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
579,074
Previous 694,056 16.57%
Holding current value
$30.8 Million
Previous $39 Million 35.72%
% of portfolio
0.58%
Previous 0.78%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$43.04 - $58.51 $4.95 Million - $6.73 Million
-114,982 Reduced 16.57%
579,074 $25.1 Million
Q4 2024

Feb 14, 2025
SELL
$49.33 - $71.97 $37.3 Million - $54.4 Million
-755,409 Reduced 52.12%
694,056 $39 Million
Q3 2024

Nov 14, 2024
BUY
$42.43 - $70.83 $12.3 Million - $20.6 Million
290,585 Added 25.07%
1,449,465 $98.7 Million
Q2 2024

Aug 14, 2024
BUY
$41.33 - $74.26 $841,230 - $1.51 Million
20,354 Added 1.79%
1,158,880 $49 Million
Q1 2024

May 15, 2024
BUY
$56.27 - $73.77 $5.11 Million - $6.69 Million
90,740 Added 8.66%
1,138,526 $78.6 Million
Q4 2023

Feb 14, 2024
SELL
$59.06 - $75.72 $4.25 Million - $5.45 Million
-72,033 Reduced 6.43%
1,047,786 $77.5 Million
Q3 2023

Nov 14, 2023
BUY
$65.94 - $99.04 $7.45 Million - $11.2 Million
113,047 Added 11.23%
1,119,819 $76.4 Million
Q2 2023

Aug 14, 2023
SELL
$62.68 - $95.05 $13.7 Million - $20.7 Million
-218,270 Reduced 17.82%
1,006,772 $94.5 Million
Q1 2023

May 15, 2023
SELL
$47.19 - $70.77 $4.1 Million - $6.16 Million
-86,973 Reduced 6.63%
1,225,042 $83.1 Million
Q4 2022

Feb 14, 2023
BUY
$30.35 - $53.15 $5.53 Million - $9.69 Million
182,362 Added 16.14%
1,312,015 $65 Million
Q3 2022

Nov 14, 2022
BUY
$31.97 - $49.37 $11.9 Million - $18.3 Million
371,630 Added 49.03%
1,129,653 $36.7 Million
Q2 2022

Aug 11, 2022
BUY
$35.61 - $76.23 $1.38 Million - $2.95 Million
38,720 Added 5.38%
758,023 $29.9 Million
Q1 2022

May 13, 2022
BUY
$57.56 - $82.54 $4.42 Million - $6.33 Million
76,721 Added 11.94%
719,303 $50.3 Million
Q4 2021

Feb 10, 2022
BUY
$72.5 - $100.68 $15.5 Million - $21.5 Million
213,309 Added 49.69%
642,582 $50 Million
Q3 2021

Nov 12, 2021
BUY
$90.24 - $124.05 $13.9 Million - $19.1 Million
153,600 Added 55.72%
429,273 $41 Million
Q2 2021

Aug 12, 2021
BUY
$93.66 - $139.27 $5.39 Million - $8.01 Million
57,533 Added 26.37%
275,673 $34.3 Million
Q1 2021

May 12, 2021
BUY
$116.57 - $155.01 $2.7 Million - $3.59 Million
23,140 Added 11.87%
218,140 $28.7 Million
Q4 2020

Feb 16, 2021
SELL
$99.61 - $142.12 $10.9 Million - $15.6 Million
-109,490 Reduced 35.96%
195,000 $25.8 Million
Q3 2020

Nov 16, 2020
BUY
$72.92 - $102.01 $22.2 Million - $31.1 Million
304,490 New
304,490 $31 Million

Others Institutions Holding EXAS

# of Institutions
645
Shares Held
157M
Call Options Held
1.74M
Put Options Held
1.56M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.4B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email